Safety and Efficacy of Autologous Hematopoietic Stem-Cell Transplantation with Low-Dose Cyclophosphamide Mobilisation and Reduced Intensity Conditioning Versus Standard of Care in Refractory Crohn’s Disease (ASTIClite)

Participants were centrally randomly assigned, 2:1, to either HSCT with a reduced dose of cyclophosphamide (intervention group) or standard care (control group).
[Lancet Gastroenterology and Hepatology]
Full Article